Danaher Corporation (LON:0R2B)
Market Cap | 113.65B |
Revenue (ttm) | 19.07B |
Net Income (ttm) | 3.11B |
Shares Out | n/a |
EPS (ttm) | 4.23 |
PE Ratio | 36.49 |
Forward PE | n/a |
Dividend | 0.88 (0.41%) |
Ex-Dividend Date | Mar 28, 2025 |
Volume | 622 |
Average Volume | 12,371 |
Open | 210.15 |
Previous Close | 208.66 |
Day's Range | 208.25 - 212.22 |
52-Week Range | 182.16 - 269.23 |
Beta | 0.85 |
RSI | 50.65 |
Earnings Date | Apr 22, 2025 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manuf... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews

Danaher Schedules First Quarter 2025 Earnings Conference Call
WASHINGTON , March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 ...
Danaher Stock Has Fallen Far Enough. Buy It Now, Says Analyst.

Unpacking the Latest Options Trading Trends in Danaher
Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher . Looking at options history for Danaher (NYSE: DHR) we detected 10 trades. If we consider the specifics of each ...
Danaher upgraded to Buy at Stifel on top-line growth opportunities
Unlocking Intrinsic Value: Analysis of Danaher Corp
Unlocking Intrinsic Value: Analysis of Danaher Corp

Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu BREA, Calif. , March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagn...
Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript
Danaher Corporation (NYSE:DHR) TD Cowen 45th Annual Health Care Conference Call March 5, 2025 10:30 AM ETCompany ParticipantsRainer Blair – President and...

Danaher to Present at TD Cowen Health Care Conference
WASHINGTON , Feb. 25, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conferen...

Industrial Laser Marking Machine Market To Reach USD 6.41 Billion by 2032, Growing at CAGR 8.1% | Coherent, Inc., Danaher Corporation, Epilog Laser
An industrial laser marking machine uses laser technology to engrave, etch, or mark materials with precision for identification, branding, or tracking. An industrial laser marking machine uses laser t...
Decoding Danaher Corp (DHR): A Strategic SWOT Insight
Decoding Danaher Corp (DHR): A Strategic SWOT Insight
Danaher Corporation (DHR) Announces Director Appointment and Stock Plan Amendment
Danaher Corporation (DHR) Announces Director Appointment and Stock Plan Amendment
Danaher raises dividend by 18.5%

Danaher Announces Appointment of Charles Lamanna to Danaher Board
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Commi...

Danaher Increases Quarterly Dividend
WASHINGTON , Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common s...

P/E Ratio Insights for Danaher
In the current session, Danaher Inc. (NYSE: DHR) is trading at $204.95, after a 0.01% decrease. Over the past month, the stock decreased by 16.56% , and in the past year, by 19.25% . With performance...

Danaher: Self-Inflicted Pessimism?
Danaher Corp. has faced market punishment recently, but maintains strong margins and impressive FCF despite a tough year, indicating resilience and potential for future growth. The company's strategic...

All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend...

Danaher's Options Frenzy: What You Need to Know
Deep-pocketed investors have adopted a bearish approach towards Danaher (NYSE: DHR), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled th...
3 Top Value Stocks to Buy and Hold for 2025
These high-quality companies are solid—and their stocks look cheap.

Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth
I started investing with a modest $4,000, now growing it into a 23-stock portfolio. The median net worth varies by age, but most can invest $10,000 for growth. The goal here isn't to push random picks...

Danaher Unusual Options Activity For February 07
Investors with a lot of money to spend have taken a bullish stance on Danaher (NYSE: DHR). And retail traders should know. We noticed this today when the positions showed up on publicly available opt...

Lightning Round: Let A10 come in a little, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Nextera Energy, Danaher, Fastly, SLB, and A10.

Danaher's Options: A Look at What the Big Money is Thinking
High-rolling investors have positioned themselves bullish on Danaher (NYSE: DHR), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tra...

This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Cancer Diagnostics Market Size is Expected to Reach USD 178.26 Billion by 2033, Growing at a CAGR of 5.91%: Straits Research
New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Cancer diagnostics is the process of identifying biomarkers, proteins, and other indicators that assist in identifying a cancerous tumor. Pla...